Pemberton is supporting Oakley Capital’s acquisition of WindStar Medical
Overview
Pemberton, the asset manager backed by one of Europe’s largest insurers, Legal & General Group PLC, is supporting Oakley Capital’s acquisition of a majority stake in WindStar Medical, a leading German over-the-counter consumer healthcare company, as the sole provider of debt financing.
WindStar Medical designs, develops and commercialises a range of both branded and private label consumer health products, primarily in the German market. It is a strategic partner to the leading drugstores in Germany, who benefit from WindStar’s portfolio of attractive branded products, and the company’s experience in developing innovative health products for their private label portfolios.
Oakley will support the Company’s management team as they continue to drive revenue growth, product innovation, digitalisation, as well as identifying opportunities to scale the business through accretive acquisitions. Pemberton is supporting Oakley Capital and WindStar Medical with the provision of debt financing via its Mid-Market Debt Strategy.
WindStar Medical operates in the attractive and resilient consumer healthcare sector, which benefits from a number of long-term structural growth trends. We are pleased to be supporting Oakley Capital in an investment in their core Consumer sector, where they have gained particular expertise in marketing and building digital sales channels.
Pemberton’s platform was purpose-built to support companies with strong growth potential and sponsors with unrivalled expertise in furthering their portfolio companies’ ambitions. WindStar Medical and Oakley Capital are both perfect examples of this, and we are excited to provide capital to help Windstar Medical to pursue a growth strategy and intensify the digitalisation of its business model.
– Jürgen Breuer, Head of DACH & Nordics at Pemberton
